Jason Glanz, PhD

Jason Glanz, PhD, is an epidemiologist and investigator at the Institute for Health Research. He is also an Assistant Professor of Epidemiology in the Department of Epidemiology, Colorado School of Public Health. Dr. Glanz’s research focuses on vaccine safety and vaccine hesitancy. He is currently a co-principal investigator for the Vaccine Safety Datalink, a national CDC-funded project that examines the safety of vaccines and also leads research efforts to develop risk communication tools to reduce parental vaccination concerns. 


A Randomized Intervention Trial of a Vaccine Social Media Website
The objective is to conduct a randomized trial to evaluate the effectiveness of using social media technologies to improve immunization rates among parents who are concerned about vaccinating their children.
Funder: Agency for Healthcare Research and Quality

Vaccine Safety Datalink: Comprehensive Link Data Collection of Medical Events and Immunization

To investigate the safety of vaccines in children and adults in a large national cohort.
Funder: Centers for Disease Control and Prevention/ America's Health Insurance Plans

Scalable PArtnering Network for CER: Across Lifespan, Conditions and Settings

The objective is to develop a distributed research network that is interoperable across a range of health care systems and sites, incorporating large and diverse patient populations.  The network infrastructure will have the capability to conduct large comparative effectiveness research (CER) studies using data collected on patient-reported outcomes collected at the point of care and real-time data collection.
Funder: Agency for Healthcare Research and Quality


Vaccine Refusal: Clinical Impact and Parental Attitudes

The objective is assess the disease risks associated with parental vaccine refusal and to assess the knowledge, attitudes and beliefs of parents who choose not to vaccinate their children
Funder: National Institute of Allergy and Infectious Disease

An Evaluation of an Interactive Social Media Website for Parents who are Concerned about Immunizing Their Children

Conduct a formative and summative evaluation of a social media website design to allay parents concerns about vaccinations, and to use the data collected in the evaluation to design a large, randomized intervention trial to evaluate the efficacy of the website in ambulatory care setting
Funder: Agency for Healthcare Research and Quality

Population Based Data to Answer Questions of Public Health Importance Regarding Biological Products/Immune Thrombocytopenia Pupura After Live Virus and Influenza Vaccines

The major goal is to provide rapid evaluation of adverse events, including rare and serious events, after vaccine administration, blood or tissue administration/transplantation near real time.
Funder: United States Food and Drug Administration Center for Biologics Evaluation and Research

Population Based Surveillance for Influenza

Monitor influenza activity across 8 Managed Care Organizations across the United States.
Funder: Centers for Disease Control and Prevention/ America's Health Insurance Plans

Immune Thrombocytopenia Pupura After Live Virus and Influenza Vaccines

Funder: United States Food and Drug Administration Center for Biologics Evaluation and Research


Tseng HF, Sy LS, Qian L, Marcy SM, Jackson LA, Glanz J, Nordin J, Baxter R, Naleway A, Donahue J, Weintraub E, & Jacobsen SJ. Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population. Clinical Infectious Diseases 2013;56(3): 315-321. PMID: 23196953

Xu S, Hambidge SJ, McClure DL, Daley MF, & Glanz JM. A scan statistic for identifying optimal risk windows in vaccine safety studies using self-controlled case series design. Statistics in Medicine 2013;Jan 10 [epub ahead of print]. PMID: 23303643

Narwaney KJ, Glanz JM, Norris JM, Fingerlin TE, Hokanson JE, Rewers M, & Hambidge SJ. Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children. Vaccine 2013;31(7):1123-1128. PMID :23261040

Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, Destefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, & Belongia EA. Trivalent Inactivated Influenza Vaccine and Spontaneous Abortion. Obstetrics and Gynecology 2013;121(1):159-165. PMID: 23262941

Glanz JM, Newcomer SR, Narwaney KJ, Hambidge SJ, Daley MF, Wagner NM, McClure DL, Xu S, Rowhani-Rahbar A, Lee GM, Nelson JC, Donahue JG, Naleway AL, Nordin JD, Lugg MM, & Weintraub ES. A Population-Based Cohort Study of Undervaccination in 8 Managed Care Organizations Across the United States. JAMA Pediatrics 2013; 167(3): 274-281. PMID:23338829

Calcaterra S, Glanz J, & Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. Drug and Alcohol Dependence 2013Jan 4 [epub ahead of print]. PMID: 23294765

McClure DL, Xu S, Weintraub E, Glanz JM. An efficient statistical algorithm for a temporal scan statistic applied to vaccine safety analyses. Vaccine 2012; 30(27):3986-3991. PMID: 22531555

Greene SK, Shay DK, Yin R, McCarthy NL, Baxter R, Jackson ML, Jacobsen SJ, Nordin JD, Irving SA, Naleway AL, Glanz JM, Lieu TA. Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010.  Influenza and Other Respiratory Viruses 2012; 6(6):e143-e151. PMID: 22687171

Klein M, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson L, Nordin J, Lieu T, Belongia EA, Fireman B, for the Vaccine Safety Datalink. No Association between Measles-Containing Vaccines and Febrile Seizures in Children Age 4 to 6 Years. Pediatrics 2012 May; 129(5):809-814. PMID: 22473362

Binswanger IA, Nowels C, Corsi KF, Glanz J, Long J, Booth RE, Steiner JF. Return to drug use and overdose after release from prison: a qualitative study of risk and protective factors. Addiction Science and Clinical Practice 2012:7(3). doi:10.1186/1940-0640-7-3

Shui I, Baggs J, Patel M, Parashar U, Rett M, Belongia E, Hambidge S, Glanz J, Klein N, Weintraub E. Risk of Intussusception Following Administration of a Pentavalent Rotavirus Vaccine in US Infants. Journal of the American Medical Association 2012; 307(6): 598-604. PMID: 22318281  

Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, Shoup JA, Narwaney K, Baggs J, Weintraub E. Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children. Pediatrics 2012; 129(1): e54-e59. PMID: 22159132

Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM, Glanz J, Hambidge S, Daley M.  Signal Identification and Evaluation for Risk of Seizures in Children Following Trivalent Inactivated Influenza Vaccine in the Vaccine Safety Datalink Project, 2010-2011. Vaccine 2012; 30(11): 2024-2031 PMID: 22361304

O’Leary ST, Glanz JM, McClure DL, Akhtar A, Daley MF, Nakasato C, Baxter R, Davis R, Izurieta  H, Lieu T, Ball R. The Risk of Immune Thrombocytopenic Purpura after Vaccination in Children and Adolescents. Pediatrics 2012; 129(2):248-255. PMID: 22232308

Hansen C, Desai S, Cheetham C, Li D, Raebel M, Glanz J, Bredfeldt C, Hemmes M, Davis R. . PS1-17: H1N1 flu and pregnancy: The Kaiser Permanente Experience. Clinical Medicine & Research 2011; 9(3-4): 155. doi:10.3121/cmr.2011.1020.ps1-17

Hambidge SJ, Ross J et al. Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalization in adults for a large cohort. Vaccine 2011; 29(46):8179-8181. PMID: 21930176

Daley MF, Glanz JM. Straight talk about vaccination: Parents need better information, ideally before a baby is born. Scientific American 2011; 305: 32-34. PMID: 21870438

Glanz JM, Newcomer SR, Hambidge SJ et al. Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink. Archives of Pediatrics & Adolescent Medicine 2011; 165(8):749-755. PMID: 21810637

Baggs J, Gee J, Lewis E et al. The Vaccine Safety Datalink: a model for monitoring immunization safety. Pediatrics 2011; 127 Suppl 1:S45-S53. PMID: 21502240

Nelson CA, France EK, Shetterly SM, Glanz JM. Seasonal Influenza Vaccination Status Among Children With Laboratory Evidence of Pandemic H1N1 Infection. Pediatric Infectious Disease Journal 2011; 30(7): 562-565. PMID: 21248657

Glanz JM, McClure DL, O'Leary ST et al. Parental decline of pneumococcal vaccination and risk of pneumococcal related disease in children. Vaccine 2011; 29(5):994-999. PMID: 21145372

Xu S, Zhang L, Nelson JC et al. Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Statistics in Medicine 2011; 30(7): 742-752. PMID: 21394750

Glanz JM, McClure DL, Magid DJ, Daley MF, France EK, Hambidge SJ. Parental refusal of varicella vaccination and the associated risk of varicella infection in children. Archives of Pediatric & Adolescent Medicine 2010; 164(1):66-70. PMID: 20048244

Greene SK, Kulldorff M, Lewis EM, Li R, Yin R, Weintraub ES, Fireman BH, Lieu TA, Nordin JD, Glanz JM, Baxter R, Jacobsen SJ, Broder KR, Lee GM.. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. American Journal of Epidemiology 2010; 171(2):177-188. PMID: 19965887

Naleway AL, Belongia EA, Donahue JG, Kieke BA, Glanz JM. Risk of immune hemolytic anemia in children following immunization. Vaccine 2009; 27(52):7394-7397. PMID: 19766577

Glanz JM, McClure DL, Magid DL, Daley MF, France EK, Hambidge SJ . Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children. Pediatrics 2009; 123(6):1446-1451. PMID: 19482753

Donahue JG, Kieke BA, Yih WK, Berger NR, McCauley JS, Baggs J, Zangwill KM, Baxter R, Eriksen EM, Glanz JM, Hambidge SJ, Klein NP, Lewis EM,Marcy SM, Naleway AL, Nordin JD, Ray P, Belongia EA; Vaccine Safety DataLink Team.. Varicella vaccination and ischemic stroke in children: is there an association? Pediatrics 2009; 123(2):e228-e234. PMID: 19171574

McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J. Comparison of epidemiologic methods for active surveillance of vaccine safety. Vaccine 2008; 26(26):3341-3345. PMID: 18462849

France EK, Glanz J, Xu S et al. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics 2008; 121(3):e687-e692. PMID: 18310189

Glanz J, France E, Xu S, Hayes T, Hambidge S. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 2008; 121(3):e506-e512. PMID: 18310170

Hambidge SJ, Glanz JM, France EK et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. Journal of the American Medical Association 2006; 296(16):1990-1997. PMID: 17062862

Glanz JM, McClure DL, Xu S et al. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Journal of Clinical Epidemiology 2006; 59(8):808-818. PMID: 16828674

Koester S, Glanz J, Baron A. Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention. AIDS and Behavior 2005; 9(1):27-39 PMID: 15812611

France EK, Glanz JM, Xu S et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Archives of Pediatrics & Adolescent Medicine 2004; 158(11):1031-1036. PMID: 15520339

Glanz J, Grant B, Monteiro M, Tabakoff B. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism.  Alcoholism: Clinical and Experimental Research 2002; 26(7):1047-1061. PMID: 12170115

Hoffman PL, Glanz J, Tabakoff B. Platelet adenylyl cyclase activity as a state or trait marker in alcohol dependence: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence. Alcoholism: Clinical and Experimental Research 2002; 26(7):1078-1087. PMID: 12170118

Snell LD, Glanz J, Tabakoff B. Relationships between effects of smoking, gender, and alcohol dependence on platelet monoamine oxidase-B: activity, affinity labeling, and protein measurements. Alcoholism: Clinical and Experimental Research 2002; 26(7):1105-1113. PMID: 12170121

Book Chapters
Chen RT, Glanz JM, Vellozzi C. Pharmacoepidemiologic Studies of Vaccine Safety. In Pharmacoepidemiology (5th edn.) Strom BL (ed.). Wiley: Chichester 2011.